{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:40:15Z","timestamp":1790890815527,"version":"4.1.0"},"reference-count":92,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Microbiol Rev"],"published-print":{"date-parts":[[2008,1]]},"abstract":"<jats:sec>\n            <jats:title>SUMMARY<\/jats:title>\n            <jats:p>Rotavirus infection is the most common cause of severe diarrhea disease in infants and young children worldwide and continues to have a major global impact on childhood morbidity and mortality. Vaccination is the only control measure likely to have a significant impact on the incidence of severe dehydrating rotavirus disease. In 1999, a highly efficacious rotavirus vaccine licensed in the United States, RotaShield, was withdrawn from the market after 14 months because of its association with intussusception. Two new live, oral, attenuated rotavirus vaccines were licensed in 2006: the pentavalent bovine-human reassortant vaccine (RotaTeq) and the monovalent human rotavirus vaccine (Rotarix). Both vaccines have demonstrated very good safety and efficacy profiles in large clinical trials in western industrialized countries and in Latin America. Careful surveillance has not revealed any increased risk of intussusception in the vaccinated groups with either vaccine. The new rotavirus vaccines are now introduced for routine use in a number of industrialized and developing countries. These new safe and effective rotavirus vaccines offer the best hope of reducing the toll of acute rotavirus gastroenteritis in both developed and developing countries.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1128\/cmr.00029-07","type":"journal-article","created":{"date-parts":[[2008,1,18]],"date-time":"2008-01-18T00:57:54Z","timestamp":1200617874000},"page":"198-208","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":262,"title":["Rotavirus Vaccines: an Overview"],"prefix":"10.1128","volume":"21","author":[{"given":"Penelope H.","family":"Dennehy","sequence":"first","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Hasbro Children's Hospital, Department of Pediatrics, The Warren Alpert Medical School of Brown University, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1692"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.272.5258.101"},{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1086\/510853","volume":"195","year":"2007","unstructured":"Banerjee, I., B. P. Gladstone, A. M. Le Fevre, S. Ramani, M. Iturriza-Gomara, J. J. Gray, D. W. Brown, M. K. Estes, J. P. Muliyil, S. Jaffar, and G. Kang. 2007. Neonatal infection with G10P[11] rotavirus did not confer protection against subsequent rotavirus infection in a community cohort in Vellore, South India. J. Infect. Dis.195:625-632.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00235-9"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)12106-2"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.2.282"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.05.001"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198307143090203"},{"key":"e_1_3_1_10_2","first-page":"1281","year":"1973","unstructured":"Bishop, R. F., G. P. Davidson, I. H. Holmes, and B. J. Ruck. 1973. Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancetii:1281-1283.","journal-title":"Lancet"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-2058"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14687-9"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040121"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.18.1.71-78.1983"},{"key":"e_1_3_1_15_2","first-page":"577","volume":"48","year":"1999","unstructured":"Centers for Disease Control and Prevention. 1999. Intussusception among recipients of rotavirus vaccine\u2014United States, 1998-1999. MMWR Morb. Mortal. Wkly. Rep.48:577-581.","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_1_16_2","first-page":"218","volume":"56","year":"2007","unstructured":"Centers for Disease Control and Prevention. 2007. Postmarketing monitoring of intussusception after RotaTeq vaccination\u2014United States, February 1, 2006-February 15, 2007. MMWR Morb. Mortal. Wkly. Rep.56:218-222.","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_1_17_2","first-page":"1","volume":"48","year":"1999","unstructured":"Centers for Disease Control and Prevention. 1999. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly. Rep.48:1-20.","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20351"},{"key":"e_1_3_1_19_2","first-page":"1333","volume":"193","year":"2006","unstructured":"Chiappini, E., L. Galli, and M. de Martino. 2006. Viremia and clinical manifestations in children with rotavirus infection. J. Infect. Dis.193:1333.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_20_2","first-page":"417","year":"1986","unstructured":"Chiba, S., T. Yokoyama, S. Nakata, Y. Morita, T. Urasawa, K. Taniguchi, S. Urasawa, and T. Nakao. 1986. Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. Lancetii:417-421.","journal-title":"Lancet"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-198809000-00009"},{"key":"e_1_3_1_22_2","first-page":"1176","year":"1978","unstructured":"Chrystie, I. L., B. M. Totterdell, and J. E. Banatvala. 1978. Asymptomatic endemic rotavirus infections in the newborn. Lanceti:1176-1178.","journal-title":"Lancet"},{"key":"e_1_3_1_23_2","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/infdis\/158.3.570","volume":"158","year":"1988","unstructured":"Clark, H. F., F. E. Borian, L. M. Bell, K. Modesto, V. Gouvea, and S. A. Plotkin. 1988. Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J. Infect. Dis.158:570-587.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-198511000-00006"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00242-0"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007958914141"},{"key":"e_1_3_1_27_2","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.287.11.1455","volume":"287","year":"2002","unstructured":"Danovaro-Holliday, M. C., A. L. Wood, and C. W. LeBaron. 2002. Rotavirus vaccine and the news media, 1987-2001. JAMA287:1455-1462.","journal-title":"JAMA"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.31.1.165-169.1993"},{"key":"e_1_3_1_29_2","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1542\/peds.107.5.1158","volume":"107","year":"2001","unstructured":"Feudtner, C., and E. K. Marcuse. 2001. Ethics and immunization policy: promoting dialogue to sustain consensus. Pediatrics107:1158-1164.","journal-title":"Pediatrics"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1086\/342294"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1086\/512863"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.12.048"},{"key":"e_1_3_1_33_2","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1093\/infdis\/174.Supplement_1.S47","volume":"174","year":"1996","unstructured":"Franco, M. A., N. Feng, and H. B. Greenberg. 1996. Molecular determinants of immunity and pathogenicity of rotavirus infection in the mouse model. J. Infect. Dis.174(Suppl. 1):S47-S50.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1086\/431499"},{"key":"e_1_3_1_35_2","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1086\/431498","volume":"192","year":"2005","unstructured":"Glass, R. I., M. K. Bhan, P. Ray, R. Bahl, U. D. Parashar, H. Greenberg, C. D. Rao, N. Bhandari, Y. Maldonado, R. L. Ward, D. I. Bernstein, and J. R. Gentsch. 2005. Development of candidate rotavirus vaccines derived from neonatal strains in India. J. Infect. Dis.192(Suppl. 1):S30-S35.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_36_2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/0-387-33026-7_5","volume":"582","year":"2006","unstructured":"Glass, R. I., J. Bresee, B. Jiang, U. Parashar, E. Yee, and J. Gentsch. 2006. Rotavirus and rotavirus vaccines. Adv. Exp. Med. Biol.582:45-54.","journal-title":"Adv. Exp. Med. Biol."},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.Supplement_1.S5"},{"key":"e_1_3_1_38_2","first-page":"1342","year":"1987","unstructured":"Hanlon, P., L. Hanlon, V. Marsh, P. Byass, F. Shenton, M. Hassan-King, O. Jobe, H. Sillah, R. Hayes, B. H. M'Boge, et al. 1987. Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants. Lanceti:1342-1345.","journal-title":"Lancet"},{"key":"e_1_3_1_39_2","first-page":"5","volume":"18","year":"2000","unstructured":"Hoshino, Y., and A. Z. Kapikian. 2000. Rotavirus serotypes: classification and importance in epidemiology, immunity, and vaccine development. J. Health Popul. Nutr.18:5-14.","journal-title":"J. Health Popul. Nutr."},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0966-842X(94)90629-7"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1086\/340103"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199605000-00004"},{"key":"e_1_3_1_43_2","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(97)05118-0","volume":"350","year":"1997","unstructured":"Joensuu, J., E. Koskenniemi, X. L. Pang, and T. Vesikari. 1997. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet350:1205-1209.","journal-title":"Lancet"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(81)90285-3"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.Supplement_1.S65"},{"key":"e_1_3_1_46_2","first-page":"163","volume":"12","year":"1996","unstructured":"Kapikian, A. Z., Y. Hoshino, R. M. Chanock, and I. Perez-Schael. 1996. Jennerian and modified Jennerian approach to vaccination against rotavirus diarrhea using a quadrivalent rhesus rotavirus (RRV) and human-RRV reassortant vaccine. Arch. Virol. Suppl.12:163-175.","journal-title":"Arch. Virol. Suppl."},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1086\/431510"},{"key":"e_1_3_1_48_2","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/jama.1995.03530140055032","volume":"274","year":"1995","unstructured":"Kilgore, P. E., R. C. Holman, M. J. Clarke, and R. I. Glass. 1995. Trends of diarrheal disease-associated mortality in US children, 1968 through 1991. JAMA274:1143-1148.","journal-title":"JAMA"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a113712"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200104000-00008"},{"key":"e_1_3_1_51_2","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/infdis\/159.3.452","volume":"159","year":"1989","unstructured":"Lanata, C. F., R. E. Black, R. del Aguila, A. Gil, H. Verastegui, G. Gerna, J. Flores, A. Z. Kapikian, and F. E. Andre. 1989. Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine. J. Infect. Dis.159:452-459.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_52_2","first-page":"983","volume":"264","year":"1990","unstructured":"LeBaron, C. W., J. Lew, R. I. Glass, J. M. Weber, G. M. Ruiz-Palacios, et al. 1990. Annual rotavirus epidemic patterns in North America. Results of a 5-year retrospective survey of 88 centers in Canada, Mexico, and the United States. JAMA264:983-988.","journal-title":"Results of a 5-year retrospective survey of 88 centers in Canada, Mexico, and the United States. JAMA"},{"key":"e_1_3_1_53_2","first-page":"1","volume":"31","year":"2001","unstructured":"Ling-Qiao, Z. 2001. A rotavirus vaccine licensed in China. Health News31:1.","journal-title":"Health News"},{"key":"e_1_3_1_54_2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1086\/505493","volume":"43","year":"2006","unstructured":"Linhares, A. C., T. Verstraeten, J. Wolleswinkel-van den Bosch, R. Clemens, and T. Breuer. 2006. Rotavirus serotype G9 is associated with more-severe disease in Latin America. Clin. Infect. Dis.43:312-314.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1086\/322650"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1086\/379322"},{"key":"e_1_3_1_57_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-2351"},{"key":"e_1_3_1_58_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/162.3.598"},{"key":"e_1_3_1_59_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.30.5.1056-1061.1992"},{"key":"e_1_3_1_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.9.3.423"},{"key":"e_1_3_1_61_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200102223440804"},{"key":"e_1_3_1_62_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200201173460317"},{"key":"e_1_3_1_63_2","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1542\/peds.103.1.e3","volume":"103","year":"1999","unstructured":"Newman, R. D., J. Grupp-Phelan, D. K. Shay, and R. L. Davis. 1999. Perinatal risk factors for infant hospitalization with viral gastroenteritis. Pediatrics103:E3.","journal-title":"Pediatrics"},{"key":"e_1_3_1_64_2","doi-asserted-by":"publisher","DOI":"10.3928\/0090-4481-20060101-11"},{"key":"e_1_3_1_65_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/169.3.504"},{"key":"e_1_3_1_66_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199606000-00015"},{"key":"e_1_3_1_67_2","first-page":"1","volume":"55","year":"2006","unstructured":"Parashar, U. D., J. P. Alexander, and R. I. Glass. 2006. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommend. Rep.55:1-13.","journal-title":"Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommend. Rep."},{"key":"e_1_3_1_68_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1202.050006"},{"key":"e_1_3_1_69_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890140206"},{"key":"e_1_3_1_70_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199710233371701"},{"key":"e_1_3_1_71_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.110.6.e67"},{"key":"e_1_3_1_72_2","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.5.4.591"},{"key":"e_1_3_1_73_2","first-page":"7","volume":"97","year":"1996","unstructured":"Rennels, M. B., R. I. Glass, P. H. Dennehy, D. I. Bernstein, M. E. Pichichero, E. T. Zito, M. E. Mack, B. L. Davidson, A. Z. Kapikian, et al. 1996. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines\u2014report of the National Multicenter Trial. Pediatrics97:7-13.","journal-title":"Pediatrics"},{"key":"e_1_3_1_74_2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archpedi.1980.02130200047015","volume":"134","year":"1980","unstructured":"Rodriguez, W. J., H. W. Kim, C. D. Brandt, B. Bise, A. Z. Kapikian, R. M. Chanock, G. Curlin, and R. H. Parrott. 1980. Rotavirus gastroenteritis in the Washington, DC, area: incidence of cases resulting in admission to the hospital. Am. J. Dis. Child.134:777-779.","journal-title":"Am. J. Dis. Child."},{"key":"e_1_3_1_75_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052434"},{"key":"e_1_3_1_76_2","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.448"},{"key":"e_1_3_1_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(97)70076-3"},{"key":"e_1_3_1_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00616-3"},{"key":"e_1_3_1_79_2","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1099\/0022-1317-68-7-1993","volume":"68","year":"1987","unstructured":"Svensson, L., H. Sheshberadaran, T. Vesikari, E. Norrby, and G. Wadell. 1987. Immune response to rotavirus polypeptides after vaccination with heterologous rotavirus vaccines (RIT 4237, RRV-1). J. Gen. Virol.68:1993-1999.","journal-title":"J. Gen. Virol."},{"key":"e_1_3_1_80_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199710000-00007"},{"key":"e_1_3_1_81_2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.inf.0000214987.67522.78","volume":"25","year":"2006","unstructured":"Turcios, R. M., A. T. Curns, R. C. Holman, I. Pandya-Smith, A. LaMonte, J. S. Bresee, and R. I. Glass. 2006. Temporal and geographic trends of rotavirus activity in the United States, 1997-2004. Pediatr. Infect. Dis. J.25:451-454.","journal-title":"Pediatr. Infect. Dis. J."},{"key":"e_1_3_1_82_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610033351404"},{"key":"e_1_3_1_83_2","doi-asserted-by":"publisher","DOI":"10.1086\/317619"},{"key":"e_1_3_1_84_2","first-page":"977","year":"1984","unstructured":"Vesikari, T., E. Isolauri, and E. D'Hondt. 1984. Protection of infants against rotavirus diarrhea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lanceti:977-981.","journal-title":"Lancet"},{"key":"e_1_3_1_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61744-9"},{"key":"e_1_3_1_86_2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/505151","volume":"194","year":"2006","unstructured":"Vesikari, T., A. V. Karvonen, J. Majuri, S. Q. Zeng, X. L. Pang, R. Kohberger, B. D. Forrest, Y. Hoshino, R. M. Chanock, and A. Z. Kapikian. 2006. Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children. J. Infect. Dis.194:370-376.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_87_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052664"},{"key":"e_1_3_1_88_2","first-page":"912","volume":"10","year":"1991","unstructured":"Vesikari, T., T. Ruuska, H. P. Koivu, K. Y. Green, J. Flores, and A. Z. Kapikian. 1991. Evaluation of the M37 human rotavirus vaccine in 2- to 6-month-old infants. Pediatr. Infect. Dis. J.10:912-917.","journal-title":"Pediatr. Infect. Dis. J."},{"key":"e_1_3_1_89_2","doi-asserted-by":"publisher","DOI":"10.1089\/088282403763635410"},{"key":"e_1_3_1_90_2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJM197908093010604","volume":"301","year":"1979","unstructured":"Wenman, W. M., D. Hinde, S. Feltham, and M. Gurwith. 1979. Rotavirus infection in adults. Results of a prospective family study. N. Engl. J. Med.301:303-306.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_1_91_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0502437102"},{"key":"e_1_3_1_92_2","first-page":"26","volume":"21","year":"2005","unstructured":"Widdowson, M. A., J. S. Bresee, J. R. Gentsch, and R. I. Glass. 2005. Rotavirus disease and its prevention. Curr. Opin. Gastroenterol.21:26-31.","journal-title":"Curr. Opin. Gastroenterol."},{"key":"e_1_3_1_93_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/148.6.1061"}],"container-title":["Clinical Microbiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CMR.00029-07","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CMR.00029-07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T11:26:20Z","timestamp":1645615580000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CMR.00029-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["10.1128\/CMR.00029-07"],"URL":"https:\/\/doi.org\/10.1128\/cmr.00029-07","relation":{},"ISSN":["0893-8512","1098-6618"],"issn-type":[{"value":"0893-8512","type":"print"},{"value":"1098-6618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"2008-01-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}